The demo is the easy part. Most people have it backwards.
A good clinical AI demo is genuinely impressive: clean input, a clear story, an output that makes the room nod. But a demo is a controlled environment, and medicine isn't. The pilot rarely dies because the technology was bad. It dies a few weeks later, quietly, when the tool meets a real clinical day.
I get to see both sides of this. I'm a hospitalist, so I know what the floor feels like at 4 p.m. with a full list and two new admissions waiting. I've also built and shipped a HIPAA-compliant clinical AI product, so I know what it takes to get something past security, past legal, and into a workflow people will actually use under pressure. The gap between those two worlds is where most pilots go to die.
A demo and a deployment are different tests
A demo rewards clarity and speed. You pick the example, you have the room's attention for ten minutes, and nothing is on fire.
A deployment rewards different things: reliability when the input is messy, trust when the clinician is rushed, and a clear answer to "who is responsible when this is wrong." Those qualities don't show up in a demo, because a demo is built to avoid the exact situations that test them.
So a tool can look excellent in the conference room and still come apart when the clinician has thirty seconds instead of ten minutes, when the patient's story is genuinely messy, when the output is subtly wrong and nobody is sure they can trust it, when compliance starts asking practical questions, and when no one can say who owns monitoring once it breaks. None of that is a model problem. It's a reality problem.
Five questions worth asking before you buy or build
Most of the value in clinical AI strategy is asking the harder questions early — before the budget and the politics are committed. Five I'd start with:
1. Clinical value. What decision or workflow does this actually improve? If the value isn't obvious to the person doing the work, adoption stays fragile no matter how good the model is.
2. Workflow fit. Where does it live in the day? If it makes clinicians leave their normal flow, document twice, or babysit the output, the friction usually eats the benefit.
3. Trust and safety. What happens when the model is confidently wrong? Clinical AI needs guardrails, a review pattern, and a clear owner of the risk — not just good average-case accuracy.
4. HIPAA and governance. Can the team explain PHI handling, audit logging, access control, retention, and BAAs in plain operational language? If they can't, the implementation risk is being underestimated.
5. Buy, build, or defer. Should this be bought from a vendor, built narrowly in-house, or simply waited on? The honest answer depends on how specific the use case is, how much it has to integrate, and how defensible it really is.
The question underneath all of it
Strategy here isn't model selection. It's judgment across clinical reality, workflow, governance, and how clinicians actually behave when they're busy.
The best products and the best deployments start from a less exciting question than "look what it can do":
What has to be true for this to work in real clinical practice?
That question doesn't demo well. It's also where almost all of the value is.
Prabhat Garg, M.D. is a practicing hospitalist and clinical AI strategy advisor. He helps health systems, health-tech companies, and investors decide what clinical AI to buy, build, avoid, and deploy.